|
2021
|
Invention
|
Pharmaceutically acceptable lectins derived from plants, fungi and bacteria for the treatment of ... |
|
|
Invention
|
6'-methoxycinchonan-9-ols for the treatment of coronaviral infections.
The present application r... |
|
|
Invention
|
6'-methoxycinchonan-9-ols for the treatment of coronaviral infections. The present application re... |
|
|
Invention
|
Inhibitors of human deubiquitinases for the treatment of coronaviral infections.
The present app... |
|
|
Invention
|
Inhibitors of human deubiquitinases for the treatment of coronaviral infections. The present appl... |
|
2016
|
Invention
|
Antiviral agents. The present invention relates to the use of a number of substances or substance... |
|
2015
|
Invention
|
Agents for the treatment of retroviral infectious diseases. The invention relates to pyridine-3,5... |
|
|
Invention
|
Substances for the treatment of retroviral infectious diseases. The invention relates to new acti... |
|
|
Invention
|
Substances for the treatment of retroviral infectious diseases. The invention relates to pyridine... |
